Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

IL-2 gene therapy for metastatic solid tumors: phase I results

Dec. 1, 1997

BE-32030B: new antitumor agent produced by Nocardia

Dec. 1, 1997

Antileukemic effects described for vesnarinone

Nov. 28, 1997

Isis antisense compound enters phase II

Nov. 28, 1997

Boehringer Ingelheim and Vion sign agreement for Promycin

Nov. 28, 1997

Immunex seeks FDA approval for generic paclitaxel injection

Nov. 28, 1997

AnorMED's AMD-473 enters phase I

Nov. 27, 1997

Stress proteins shown to activate CTL response to cancer cells

Nov. 27, 1997

Cephalon and TAP renew oncology collaboration

Nov. 27, 1997

Preclinical pharmacokinetics, antitumor activity and toxicity of CI-994

Nov. 26, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...